BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22495125)

  • 21. Pathology quiz case 2. Salivary duct carcinoma (SDC).
    Hirschi SD; Templer JW; Miick R; Frazier SR
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):947, 949-50. PubMed ID: 17875867
    [No Abstract]   [Full Text] [Related]  

  • 22. Salivary duct carcinoma of the parotid gland: the cytohistological features.
    Pai RR; Alwar V; Rao VS; Somayaji V
    Indian J Pathol Microbiol; 2007 Oct; 50(4):872-4. PubMed ID: 18306594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary duct carcinoma: clinical characteristics and treatment strategies.
    Guzzo M; Di Palma S; Grandi C; Molinari R
    Head Neck; 1997 Mar; 19(2):126-33. PubMed ID: 9059870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gingival metastasis from salivary duct carcinoma of the parotid gland.
    Bernabé DG; Veronese LA; Miyahara GI; Conrado-Neto S; Biasoli ER
    J Periodontol; 2008 Apr; 79(4):748-52. PubMed ID: 18380570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary Duct Carcinoma of the Parotid: Outcomes with a Contemporary Multidisciplinary Treatment Approach.
    Mifsud M; Sharma S; Leon M; Padhya T; Otto K; Caudell J
    Otolaryngol Head Neck Surg; 2016 Jun; 154(6):1041-6. PubMed ID: 26980918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
    Delgado R; Klimstra D; Albores-Saavedra J
    Cancer; 1996 Sep; 78(5):958-67. PubMed ID: 8780532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
    Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
    Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological factors are predictors of distant metastasis from major salivary gland carcinomas.
    Mariano FV; da Silva SD; Chulan TC; de Almeida OP; Kowalski LP
    Int J Oral Maxillofac Surg; 2011 May; 40(5):504-9. PubMed ID: 21251798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary duct carcinoma.
    Thompson LD
    Ear Nose Throat J; 2012 Sep; 91(9):356, 359. PubMed ID: 22996706
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acinar cell carcinoma of the salivary glands].
    Zbären P; Schreiber B; Lehmann W; Widgren S
    Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):320-3. PubMed ID: 3626714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major salivary gland cancer.
    Witt RL
    Surg Oncol Clin N Am; 2004 Jan; 13(1):113-27. PubMed ID: 15062365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological case report of high grade salivary duct carcinoma.
    Borovec J; Cegan M; Mala K; Harmash N; Chramosta P; Kobierzycki C; Bobek V
    Folia Histochem Cytobiol; 2015; 53(4):342-5. PubMed ID: 26691893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low to intermediate grade salivary duct carcinoma associated with osteoclast like-giant cell tumor of parotid gland: a rare case with distinct pathological features.
    Pasricha S; Gandhi JS; Mehta A; Gupta G; Pradhan T
    J Cancer Res Ther; 2013; 9(2):314-6. PubMed ID: 23771386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?
    Lee JS; Kwon OJ; Park JJ; Seo JH
    J Oral Maxillofac Surg; 2014 May; 72(5):1023-31. PubMed ID: 24480767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pagetoid spread to oral mucosa from submandibular gland salivary duct carcinoma: a case report.
    Kikuchi Y; Uozaki H; Itoyama S; Saijo H; Takato T; Fukayama M
    Hum Pathol; 2009 Jul; 40(7):1036-9. PubMed ID: 19297007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary Duct Carcinoma of the Parotid Gland: Report of Two Cases in Females.
    Shah SA; Nawazish A; Tahir M; Shah SM; Faheem M
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):105-107. PubMed ID: 28292389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature.
    Kainuma K; Oshima A; Suzuki H; Fukushima M; Shimojo H; Usami S
    Acta Otolaryngol; 2010; 130(1):185-9. PubMed ID: 19449226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma.
    van der Sangen MJ; Coebergh JW; Roumen RM; Rutten HJ; Vreugdenhil G; Voogd AC
    Cancer; 2003 Jul; 98(1):11-7. PubMed ID: 12833449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.